PF-03526299
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for PF-03526299, covering 2010-01-22 to 2011-12-02. Get the full timeline:
Most recent: Clinical Trial Update: A Study To Assess The Duration Of Action Of PF-03526299 In Asthmatic Subjects Following Allergen Challenge [Phase 1]